Literature DB >> 9771944

Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice.

M T Huang1, Y R Lou, J G Xie, W Ma, Y P Lu, P Yen, B T Zhu, H Newmark, C T Ho.   

Abstract

Female Sencar mice (6 weeks old) were administered 1 mg of 7,12-dimethylbenz[a]anthracene (DMBA) by oral gavage once a week for 5 weeks. At 20 weeks after the first dose of DMBA, 68% of mice developed mammary tumors (the average 1.08 tumors per mouse) and 45% had lymphomas/leukemias. Feeding 1% dibenzoylmethane (DBM) in AIN 76A diet, starting at 2 weeks before the first dose of DMBA and continuing until the end of the experiment, inhibited both the multiplicity and incidence of DMBA-induced mammary tumor by 97%. The incidence of lymphomas/leukemias was completely inhibited by 1% DBM diet. In contrast, feeding 2% curcumin diet had little or no effect on the incidence of mammary tumors, and the incidence of lymphomas/leukemias was reduced by 53%.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771944     DOI: 10.1093/carcin/19.9.1697

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  29 in total

1.  Curcumin implants, not curcumin diet, inhibit estrogen-induced mammary carcinogenesis in ACI rats.

Authors:  Shyam S Bansal; Hina Kausar; Manicka V Vadhanam; Srivani Ravoori; Jianmin Pan; Shesh N Rai; Ramesh C Gupta
Journal:  Cancer Prev Res (Phila)       Date:  2014-02-05

2.  [DLys(6)]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo.

Authors:  S Aggarwal; M W Ndinguri; R Solipuram; N Wakamatsu; R P Hammer; D Ingram; W Hansel
Journal:  Int J Cancer       Date:  2011-07-20       Impact factor: 7.396

3.  Pharmacokinetics of dietary cancer chemopreventive compound dibenzoylmethane in rats and the impact of nanoemulsion and genetic knockout of Nrf2 on its disposition.

Authors:  Wen Lin; Jin-Liern Hong; Guoxiang Shen; Rachel T Wu; Yuwen Wang; Mou-Tuan Huang; Harold L Newmark; Qingrong Huang; Tin Oo Khor; Tycho Heimbach; Ah-Ng Kong
Journal:  Biopharm Drug Dispos       Date:  2010-12-16       Impact factor: 1.627

Review 4.  Discovery of curcumin, a component of golden spice, and its miraculous biological activities.

Authors:  Subash C Gupta; Sridevi Patchva; Wonil Koh; Bharat B Aggarwal
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-03       Impact factor: 2.557

5.  Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: role of Michael acceptors and Michael donors.

Authors:  Preetha Anand; Bokyung Sung; Ajaikumar B Kunnumakkara; Kallikat N Rajasekharan; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2011-09-08       Impact factor: 5.858

6.  DM-1, sodium 4-[5-(4-hydroxy-3-methoxyphenyl)-3-oxo-penta-1,4-dienyl]-2-methoxy-phenolate: a curcumin analog with a synergic effect in combination with paclitaxel in breast cancer treatment.

Authors:  Fernanda Faião-Flores; José Agustín Quincoces Suarez; Paulo Celso Pardi; Durvanei Augusto Maria
Journal:  Tumour Biol       Date:  2011-12-23

7.  Cytotoxic effects of curcumin on osteosarcoma cell lines.

Authors:  Denise K Walters; Roman Muff; Bettina Langsam; Walter Born; Bruno Fuchs
Journal:  Invest New Drugs       Date:  2007-12-11       Impact factor: 3.850

Review 8.  Perspectives on new synthetic curcumin analogs and their potential anticancer properties.

Authors:  Alok Vyas; Prasad Dandawate; Subhash Padhye; Aamir Ahmad; Fazlul Sarkar
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects.

Authors:  Shaiju K Vareed; Madhuri Kakarala; Mack T Ruffin; James A Crowell; Daniel P Normolle; Zora Djuric; Dean E Brenner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-06       Impact factor: 4.254

10.  Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells.

Authors:  Beatrice E Bachmeier; Cristina M Iancu; Peter H Killian; Emanuel Kronski; Valentina Mirisola; Giovanna Angelini; Marianne Jochum; Andreas G Nerlich; Ulrich Pfeffer
Journal:  Mol Cancer       Date:  2009-12-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.